The medication belongs to a class called GLP-1 receptor agonists, originally designed to help people with type 2 diabetes manage their blood sugar
In the SURPASS clinical trial program for type 2 diabetes, patients achieved HbA1c reductions of 1.9% to 2.6% depending on dose, with weight loss averaging 15-22 pounds across studies
* The initial weight loss consultation fee does not include the cost of Semaglutide or Tirzepatide medications
Yes, several dietary strategies and supplements have been shown to boost GLP-1 production, including high-protein foods, olive oil, fermentable fiber, allulose, berberine, EGCG, and curcumin
Who we are Dietitians On Demand is the nationwide leader in providing dietitians with jobs they love